Shareholders' Equity and Capital Stock - Schedule of activity with respect to RSUs outstanding (Details) |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
$ / shares
shares
| |
| Shareholders' Equity and Capital Stock | |
| Number of RSUs Unvested, Beginning Balance | 1,069,645 |
| Number of RSUs Granted | 0 |
| Number of RSUs Redeemed | (307,067) |
| Number of RSUs Unvested, Ending Balance | 762,578 |
| Number of RSUs unvested, weighted average grant date fair value, beginning balance | $ / shares | $ 1.29 |
| Redeemed, Weighted average grant date fair value | $ / shares | 1.15 |
| Number of RSUs unvested, weighted average grant date fair value, ending balance | $ / shares | $ 1.35 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|